✦ LIBER ✦

Continuous GLP-1 (7−36) amide effective in type 2 diabetes

✍ Scribed by Poole, Raewyn

Book ID: 120862974
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2002
Weight: 139 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200213290-00016

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

GLP-1 7-36 amide: potential in type 2 di

GLP-1 7-36 amide: potential in type 2 diabetes

📂 Article 📅 2000 🏛 Adis International Limited (now part of Wolters Kl ⚖ 138 KB

GLP-1 7-36 amide: encouraging results in

GLP-1 7-36 amide: encouraging results in type 2 diabetes

📂 Article 📅 2001 🏛 Adis International Limited (now part of Wolters Kl ⚖ 121 KB

GLP-1 7-36 amide beneficial in elderly w

GLP-1 7-36 amide beneficial in elderly with type 2 diabetes?

📂 Article 📅 2003 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Normalization of fasting glycaemia by in

Normalization of fasting glycaemia by intravenous GLP-1 ([7-36 amide] or [7-37]) in Type 2 diabetic patients

✍ Nauck, M.A.; Weber, I.; Bach, I.; Richter, S.; Ørskov, C.; Holst, J.J.; Schmiege 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 185 KB

Intravenous GLP-1 [7-36 amide] can normalize fasting hyperglycaemia in Type 2 diabetic patients. Whether GLP-1 [7-37] has similar effects and how quickly plasma glucose concentrations revert to hyperglycaemia after stopping GLP-1 is not known. Therefore, 8 patients with Type 2 diabetes (5 female, 3

Glucagon-like peptide-1 7-36 amide impro

Glucagon-like peptide-1 7-36 amide improves glucose levels in type 2 diabetes

📂 Article 📅 2001 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Endogenous GLP-1(7-36)amide (GLP-1) redu

Endogenous GLP-1(7-36)amide (GLP-1) reduces perception of gastric distention in humans

✍ Joerg Chirra; Claudia Craney; Mathias Nicolaus; Rudolf Arnold; Burkhard Goeke; M 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 169 KB